← Eichor
Study identifier: NCT07676981 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Atropine Eye Drops for Watery Eyes (Excessive Tearing)

Condition: Epiphora  ·  Sponsor: Rehan Ahmed

PhasePhase 2
Planned participants18
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if low-dose atropine eye drops work to reduce excessive watery eyes (epiphora) in adults. It will also learn about the safety of the eye drops. The main questions it aims to answer are: Do the eye drops reduce how often participants have watery eyes? What medical problems do participants have when taking the eye drops? Researchers will compare two strengths of the eye drops (0.005% and 0.01%) to see whether one works better than the other and whether the lower strength works as well as the higher one. Participants will: * Use the assigned eye drops in the affected eye(s) for one week * Visit the clinic twice for checkups and eye tests * Receive a follow-up phone call about two weeks after starting, to check on any symptoms

This description comes directly from the study's public registry record.

Talk to the study team

Rehan Ahmed  ·  713-661-6500  ·  studytearing@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Greater Houston Eye ConsultantsHouston, Texas, United StatesRecruiting
North Texas Eye SpecialistsMesquite, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07676981